Pharmafile Logo

JPT Peptide Technologies

JPT Peptide Technologies GmbH is a leading provider of innovative peptide-based services, and catalog products & kits, as well as a research and development partner for projects in Immunotherapy, Immunology, Proteomics and Drug Discovery.
JPT is ISO 9001 certified and takes pride in its excellent customer support.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Company Details

 Latest Content from PMHub 

Pegasus crowned PR Week’s Specialist Consultancy of the Year, making a hat-trick of Consultancy wins in 2016!

Press Releases | October 21, 2016 | Inizio

Pegasus, an Ashfield company, part of UDG Healthcare plc, is delighted to have been crowned Specialist Consultancy of the Year at this week’s prestigious PR Week Awards. The accolade tops...

The one multichannel question you must ask

There is a question every marketer should ask when designing a multichannel communications strategy

Lucid Group: What medical communications means to us

Katherine Duxbury, Scientific Director at Lucid, explains what medical communications means to Lucid: What we do, how we do it and what makes us different.

Lucid make the shortlist in all of the four categories they entered for the PMEA programme 2016

The PMEA programme rewards responsible customer-centric business practices that ensure treatments and advice provide patients with meaningful outcomes. The awards have been specifically designed to recognise and commend excellence, best...

Are reverse auctions the best way to procure marketing services?

Managing Director Martin Brass discusses what a reverse auction is, and whether it truly is a good way for healthcare companies to drive efficiencies when procuring marketing services.

Dr. Thomas Blatter has been appointed Vice President, DACH Region

Dr. Thomas Blatter has been appointed VP DACH region to lead Anthill’s activities in the region, effective immediately.

Lucid bolsters its senior leadership team

Lucid Group has had a successful summer attracting top talent to its senior leadership team with the appointment of Shula Sarner (Executive Scientific Director) and Tanya Goodyear (Division Director, Immunology).

IBD Oxford MasterClass 2016 harnesses the chemistry between science and clinical practice

Leading Edge, part of the Lucid Group, delivered another successful Oxford MasterClass this year, which attracted over 260 delegates and 60 international inflammatory bowel disease (IBD) faculty, representing Europe, Asia, Australasia...

Artificial Intelligence: the new healthcare algorithm

The age of computers has hugely evolved, and with the emergence of effective machine learning, pattern recognition, and decision-making algorithms, Artificial Intelligence provides a revolutionary new approach to tailored healthcare....

Lucid Group becomes a sponsor of MedComms Networking

To help Lucid access the valuable medical communications professional network they have become a sponsor of MedComms Networking, headed by Peter Llewellyn. Jan Steele (Co-founder and COO of Lucid Group)...